ASP Isotopes Schedules Capital Markets Day in London for September 8, 2026

ASP Isotopes to Host Investor-Focused Capital Markets Day Event

ASP Isotopes Inc., incorporated in Delaware and trading on NASDAQ under the symbol ASPI, revealed plans for a Capital Markets Day event in London. The announcement was filed with the SEC on July 28, 2026, coinciding with a press release detailing the event. Capital Markets Days serve as formal occasions for public companies to communicate financial results, strategic initiatives, and future objectives directly to institutional investors, analysts, and other stakeholders interested in the company’s growth and prospects.

This event marks a key investor relations milestone, providing management the opportunity to deliver in-depth updates on company strategy, operational progress, and long-term guidance. For emerging growth companies like ASP Isotopes, such events are vital for enhancing investor awareness and engagement, especially within the international investment community given the London venue.

Event Details and Scheduling

The Capital Markets Day is set for Tuesday, September 8, 2026, with registration and presentations starting at 10:00 a.m. Eastern Time, corresponding to 3:00 p.m. British Summer Time for UK and European attendees. This timing accommodates investors across North America and Europe, indicating the company’s intent to engage a broad geographic investor base. Hosting the event in London highlights ASP Isotopes’ focus on connecting with European institutional investors alongside North American participants who may attend virtually or in person.

The dual time zone disclosure underscores the company’s commitment to accessibility for a global audience. Scheduling the event in early September positions ASP Isotopes to potentially share third-quarter updates and forward guidance ahead of the typical autumn earnings season, offering strategic advantages for investor positioning.

Regulatory Filing and Forward-Looking Statements

The announcement was made via a Form 8-K current report, a filing used to disclose material events and press releases requiring prompt SEC submission. The filing clarifies that the information is not "filed" under Section 18 of the Securities Exchange Act of 1934, limiting statutory liabilities associated with filed documents. This approach aligns with Regulation FD requirements designed to ensure fair and simultaneous disclosure of material information to investors.

Included in the filing is "safe harbor" language pursuant to the Private Securities Litigation Reform Act of 1995, indicating that certain statements in the press release are forward-looking and involve risks and uncertainties. This legal protection allows ASP Isotopes to discuss future plans and expectations related to the Capital Markets Day while mitigating litigation risks if actual outcomes differ materially.

Company Profile and Emerging Growth Status

ASP Isotopes Inc., headquartered at 2200 Ross Avenue, Suite 4575E, Dallas, Texas, is a Delaware corporation with SEC File Number 001-41555 and IRS Employer Identification Number 87-2618235. Its common stock, with a par value of $0.01 per share, is listed on The Nasdaq Stock Market LLC under the ticker ASPI. These details confirm ASP Isotopes as a publicly traded company subject to SEC oversight and NASDAQ listing standards.

The company qualifies as an emerging growth company under Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Securities Exchange Act of 1934. This status provides reduced disclosure and compliance requirements compared to larger public companies, allowing phased implementation of financial reporting and governance standards. ASP Isotopes has opted not to use the extended transition period for new accounting standards, committing to comply on the same timeline as non-emerging growth companies.

Investor Communication and Outreach Strategy

By announcing a Capital Markets Day, ASP Isotopes demonstrates a strategic focus on transparent and proactive investor engagement. Hosting the event in London reflects the company’s recognition of the importance of the European investment market and its intent to strengthen relationships with European institutional investors and asset managers.

The use of a formal regulatory filing alongside a press release ensures compliance with SEC requirements for material disclosures. Filing the announcement as a current report guarantees simultaneous access to information for all investors, fulfilling Regulation FD’s fair disclosure mandate.

Context and Timing of Capital Markets Events

Capital Markets Days are increasingly common among public companies aiming to maintain investor engagement outside of earnings announcements. These events typically feature detailed presentations on business strategy, operational metrics, market opportunities, competitive advantages, and sometimes financial guidance. For emerging growth companies in niche sectors, such events are crucial for educating investors and enhancing understanding of the company’s market position and growth potential.

Scheduling the event in September 2026 strategically precedes the final quarter, a period when companies often update guidance and investors adjust portfolios for the upcoming year. The international location underscores ASP Isotopes’ global outlook and acknowledges that capital markets extend beyond North America.

Press Release and Exhibit Information

The July 28, 2026 press release was attached as Exhibit 99.1 to the current report filing and incorporated by reference. While the press release text is not fully reproduced in the filing, the reference provides investors access to the complete announcement. This exhibit method is standard in regulatory filings, enabling companies to include detailed event information without duplicating content within the filing.

The filing was signed by Donald G. Ainscow, Executive Vice President, General Counsel, and Secretary of ASP Isotopes Inc., underscoring the official nature of the announcement and confirming corporate authorization. The execution date of July 28, 2026, aligns with the public release of the event information.

Investor Implications and Market Outlook

For current and prospective investors, the Capital Markets Day presents an opportunity to gain comprehensive insights into ASP Isotopes’ operations, strategic direction, and market positioning. The event is expected to provide more detailed information than typical quarterly earnings calls or press releases, potentially including competitive analysis and strategic initiatives that could influence investment decisions. Investors should watch for further announcements regarding the event agenda, speakers, and registration details.

The immediate impact on the company’s share price was not evident from public data. However, announcing a Capital Markets Day often signals management’s confidence in the company’s outlook, as such events require significant resources and are typically conducted when positive material information is available. Market participants and analysts will likely monitor developments leading up to and during the September 8, 2026 event.